Hangzhou Clongene Biotech Co., Ltd. is a national high-tech enterprise based in Hangzhou, China. We are specializing in the R&D, production and sales of biological raw materials and IVD reagents. In addition, we can also provide CRO/CDMO services.
As a well-known global supplier of biological raw materials, we provide products and services to major IVD products manufactures and scientific research institutions. Our main IVD reagents have obtained authoritative certifications including NMPA of China, FDA 510(k) clearances of US, TGA of Australia, CE of EU and some other certifications from different countries. The products have been sold well in more than 100 countries and regions around the world. We can also provide customers with high-quality CRO/CDMO services, including protein expression services, antibody discovery services, antibody expression services and stable cell line development service.
While continuously innovating the products, we always commit to product innovation and strict quality control. We pursue to provide our customers with high-quality products and excellent service through infinite trust and responsibility.
|Biological Raw Materials||IVD Products||CRO / CDMO Services|
Colloidal gold immunoassay
Protein expression services
Antibody discovery services
Antibody expression services
Stable cell line development service
Based on the above-mentioned technology platforms, the products of Clongene Biotech mainly cover the fields of infectious diseases, drugs of abuse, fertility, inflammation, serum proteins, cardiac markers, tumor markers and animal disease.
Clongene Biotech is a one-stop solution enterprise integrating biological raw materials, detection reagents and instruments.
• High quality biological raw materials
• Multi and stable detection reagents
• Professional technical services
Clongene Biotech will continue to bring more value to companies and units around the world, and bring more opportunities to distributors and partners with rich products and professional services.
* Protein Expression Service
* Recombinant Antibody Expression Service
* Construction of CHO-K1 Stable Cell Line
COVID-19 Antigen rapid tests were listed in the first batch of EU mutual recognition list
SARS-CoV-2 detection reagents have obtained the CE certification of EU, TGA certification of Australia and AVISA certification of Brazil
*PCR technology platform
*Chemiluminescence technology platform
*Immunofluorescence technology platform
*Province-level R&D Center in Zhejiang
Obtained US FDA 510(k) Clearances
Approved as National High-tech Enterprise
*Registration certificate of NMPA
Obtained China Medical Device Manufacturer License
*Immunochromatography technology platform
*ELISA technology platform
*Genetic engineering technology platform
*Monoclonal antibody technology platform
The main IVD reagents have obtained authoritative certifications including NMPA of China, FDA 510(k) clearances of US, TGA of Australia, CE of EU and some other certifications from different countries, which demonstrate the quality of our products are approved by related government institutions.
With independent innovation capabilities and rich technical experience, Clongene has obtained dozens of invention patents and utility model patents.
Clongene has been awarded as the innovation company in the key areas with national support, the Chinese People's Liberation Army material procurement supplier, Province-level R&D Center in Zhejiang, Patent Pilot Enterprise in Hangzhou and so on.
Clongene Biotech always takes product quality as the first priority. We have a 100,000-level GMP clean production area that meets GMP requirements to ensure product safety and quality.
Clongene Biotech has passed various system certifications such as ISO 13485, ISO 9001, ISO 45001, and ISO 14001 after 18 years of development.